People · Operator
Named in public records as an officer, director or promoter · active 2008–2021 · Other, Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Payscale Holdings, Inc. | — | Other | Series C | $183.1M | $724.4M | 2014 |
| Tarveda Therapeutics, Inc. | — | Biotechnology | Series B | $127.4M | $141.9M | 2020 |
| Payscale Inc | — | Other Technology | Series A | $10.1M | $180.3M | 2008 |
Michael Metzger at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael Metzger on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Matt McIlwain | 1 | 25 |
| Peter Barton Hutt | 1 | 14 |
| Robert S Langer | 1 | 14 |
| Patricia Nakache | 1 | 11 |
| Brian Roberts | 1 | 7 |
| James Barrett | 1 | 6 |
| Omid Farokhzad | 1 | 4 |
| Nilesh Kumar | 1 | 4 |
| Justin Sadrian | 1 | 4 |
| Dennis Ausiello | 1 | 4 |
| Elena Donio | 1 | 4 |
| Jesse Levin | 1 | 4 |
| Mark Klebanoff | 1 | 4 |
| Robert S. Langer, Jr. | 1 | 3 |
| Aymeric Sallin | 1 | 3 |
| EDWIN M. KANIA | 1 | 3 |
| David Hartwig | 1 | 3 |
| Omid C. Farokhzad | 1 | 3 |
| Guido Magni | 1 | 3 |
| Dennis Weston | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.